New technologies and adaptations of existing technologies can improve platform processes.
Judy Glynn
Advertisement
Judy Glynn is senior principal scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles by Judy Glynn
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
If certain engineering challenges can be addressed, precipitation may prove to be a valuable tool for antibody purification.
Advertisement
Latest Updated Articles
Advances in Monoclonal Antibody PurificationPublished: March 2nd 2010 | Updated:
The Development and Application of a Monoclonal Antibody Purification PlatformPublished: October 2nd 2009 | Updated:
The Development and Application of a Monoclonal Antibody Purification PlatformPublished: March 2nd 2009 | Updated:
Process-Scale Precipitation of Impurities in Mammalian Cell Culture BrothPublished: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
